$134 Million is the total value of Copernicus Capital Management, LLC's 23 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AET | New | AETNA INC NEW | $10,335,000 | – | 57,291 | +100.0% | 7.69% | – |
| ILMN | New | ILLUMINA INC | $10,313,000 | – | 47,200 | +100.0% | 7.68% | – |
| DVA | New | DAVITA INC | $10,173,000 | – | 140,800 | +100.0% | 7.57% | – |
| HOLX | New | HOLOGIC INC | $9,415,000 | – | 220,240 | +100.0% | 7.01% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $9,335,000 | – | 62,291 | +100.0% | 6.95% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $8,029,000 | – | 22,000 | +100.0% | 5.98% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $6,585,000 | – | 457,617 | +100.0% | 4.90% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $6,538,000 | – | 58,010 | +100.0% | 4.87% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $6,499,000 | – | 65,742 | +100.0% | 4.84% | – |
| SYK | New | STRYKER CORP | $6,194,000 | – | 40,000 | +100.0% | 4.61% | – |
| EVHC | New | ENVISION HEALTHCARE CORP | $6,083,000 | – | 176,000 | +100.0% | 4.53% | – |
| BIIB | New | BIOGEN INC | $5,837,000 | – | 18,321 | +100.0% | 4.35% | – |
| TSRO | New | TESARO INC | $5,304,000 | – | 64,000 | +100.0% | 3.95% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $4,668,000 | – | 78,132 | +100.0% | 3.48% | – |
| ZTS | New | ZOETIS INCcl a | $4,086,000 | – | 56,718 | +100.0% | 3.04% | – |
| NUVA | New | NUVASIVE INC | $4,052,000 | – | 69,280 | +100.0% | 3.02% | – |
| New | PUMA BIOTECHNOLOGY INCcall | $3,657,000 | – | 37,000 | +100.0% | 2.72% | – | |
| MOH | New | MOLINA HEALTHCARE INC | $3,604,000 | – | 47,000 | +100.0% | 2.68% | – |
| SCI | New | SERVICE CORP INTL | $3,527,000 | – | 94,494 | +100.0% | 2.63% | – |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $2,879,000 | – | 59,149 | +100.0% | 2.14% | – |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $2,627,000 | – | 77,517 | +100.0% | 1.96% | – |
| CLVS | New | CLOVIS ONCOLOGY INC | $2,485,000 | – | 36,544 | +100.0% | 1.85% | – |
| BEAT | New | BIOTELEMETRY INC | $2,093,000 | – | 70,000 | +100.0% | 1.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 15 | Q2 2021 | 28.6% |
| THERMO FISHER SCIENTIFIC INC | 10 | Q3 2021 | 13.8% |
| ZOETIS INC | 10 | Q1 2020 | 13.0% |
| FATE THERAPEUTICS INC | 9 | Q3 2021 | 13.7% |
| ILLUMINA INC | 9 | Q4 2019 | 11.8% |
| BIOMARIN PHARMACEUTICAL INC | 8 | Q3 2021 | 14.7% |
| BRISTOL-MYERS SQUIBB CO | 8 | Q4 2020 | 12.2% |
| INTUITIVE SURGICAL INC | 7 | Q2 2019 | 11.8% |
| STRYKER CORP | 7 | Q2 2019 | 11.6% |
| IQVIA HLDGS INC | 7 | Q4 2020 | 8.2% |
View Copernicus Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
View Copernicus Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.